DACLATASVIR vs DALBAVANCIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DACLATASVIR vs DALBAVANCIN: Safety Overview
| Metric | DACLATASVIR | DALBAVANCIN |
|---|---|---|
| Total FAERS Reports | 5,602 | 1,107 |
| Deaths Reported | 581 | 54 |
| Death Rate | 10.4% | 4.9% |
| Hospitalizations | 1,637 | 288 |
| Average Patient Age | 58.1 yrs | 61.0 yrs |
| % Female Patients | 39.7% | 46.7% |
| FDA Approval Date | Apr 13, 2016 | May 23, 2014 |
| Manufacturer | N/A | Fresenius Kabi USA, LLC |
| Route | N/A | INTRAVENOUS |
| Marketing Status | Discontinued | Prescription |